ROPES WEALTH ADVISORS LLC - TOKAI PHARMACEUTICALS INC ownership

TOKAI PHARMACEUTICALS INC's ticker is TKAI and the CUSIP is 88907J107. A total of 54 filers reported holding TOKAI PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ROPES WEALTH ADVISORS LLC ownership history of TOKAI PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2016$9,000
-72.7%
6,0000.0%0.00%
-75.0%
Q2 2016$33,000
-2.9%
6,0000.0%0.01%
-20.0%
Q1 2016$34,000
-34.6%
6,0000.0%0.02%
-34.8%
Q4 2015$52,000
-16.1%
6,0000.0%0.02%
-30.3%
Q3 2015$62,000
-22.5%
6,0000.0%0.03%
-23.3%
Q2 2015$80,0006,0000.04%
Other shareholders
TOKAI PHARMACEUTICALS INC shareholders Q3 2015
NameSharesValueWeighting ↓
SENZAR ASSET MANAGEMENT, LLC 511,010$2,815,665,0000.61%
Perceptive Advisors 661,041$3,642,0000.25%
SABBY MANAGEMENT, LLC 749,205$4,128,0000.22%
Novo Holdings A/S 128,993$711,0000.08%
NJ State Employees Deferred Compensation Plan 35,000$193,0000.04%
Alyeska Investment Group, L.P. 322,297$1,776,0000.02%
PARADIGM ASSET MANAGEMENT CO LLC 17,600$96,976,0000.02%
ROPES WEALTH ADVISORS LLC 6,000$33,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 100,000$551,0000.01%
Tower Research Capital LLC (TRC) 3,262$17,0000.00%
View complete list of TOKAI PHARMACEUTICALS INC shareholders